Interpace Biosciences Asset Metrics Summary

According to Interpace Biosciences's latest annual financial reports, the company's asset profile is as follows:

Total Assets

Interpace Biosciences's total assets amount to $13.02M. This is divided into:

• Total Current Assets: $10.32M
• Total Non-current Assets: $2.70M
• Net Receivables: $4.98M
• Inventory: $1.23M
• Cash and Short-term Investments: $3.50M
• Property, Plant, and Equipment (Net): $2.65M
• Long-term Investments: $-
• Goodwill and Intangible Assets: $-

Asset Ratios and Metrics

To better understand Interpace Biosciences's asset management, we can look at several key ratios:

• Return on Assets (ROA): 6.16% - this indicates how profitable a company is relative to its total assets.
• Asset Turnover: 3.09 - this shows how efficiently a company uses its assets to generate sales.
• Current Ratio: 0.59 - this measures a company's ability to pay short-term obligations with its current assets.
• Quick Ratio: 0.52 - this indicates a company's ability to meet short-term obligations with its most liquid assets.
• Cash Ratio: 0.20 - this measures a company's ability to pay off short-term liabilities with its cash and cash equivalents.

These metrics provide insight into Interpace Biosciences's asset efficiency and liquidity. For a comprehensive understanding of the company's financial health, it's important to consider these asset metrics alongside other financial indicators and industry benchmarks.

Interpace Biosciences Historical Asset Metrics

Historical Return on Assets

Historical Total Assets Growth